Lataa...
Evolving Antibody Therapies for the Treatment of Type 1 Diabetes
Type 1 diabetes (T1D) is widely considered to be a T cell driven autoimmune disease resulting in reduced insulin production due to dysfunction/destruction of pancreatic β cells. Currently, there continues to be a need for immunotherapies that selectively reestablish persistent β cell-specific self-t...
Tallennettuna:
| Julkaisussa: | Front Immunol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7930374/ https://ncbi.nlm.nih.gov/pubmed/33679717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.624568 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|